Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,761
Total Claims
$704K
Drug Cost
775
Beneficiaries
$908
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-90%
Opioid rate vs peers
0.2% vs 2.2% avg
-36%
Cost per patient vs peers
$908 vs $1,411 avg
-7%
Brand preference vs peers
9.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.2%
Opioid Rate
21
Opioid Claims
$196
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 954 claims · $576K
Generic: 8,687 claims · $124K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 124 | $146K |
| Dulaglutide | 35 | $49K |
| Tirzepatide | 33 | $44K |
| Sitagliptin Phosphate | 34 | $40K |
| Apixaban | 47 | $38K |
| Empagliflozin | 24 | $30K |
| Fluticasone/Umeclidin/Vilanter | 39 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $24K |
| Linaclotide | 17 | $18K |
| Mirabegron | 26 | $17K |
| Tiotropium Bromide | 14 | $11K |
| Levothyroxine Sodium | 93 | $9,154 |
| Atorvastatin Calcium | 597 | $6,510 |
| Rosuvastatin Calcium | 405 | $6,465 |
| Levothyroxine Sodium | 505 | $6,439 |
Prescribing Profile
Patient Profile
74
Avg Age
86%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About